Clinical Trials Logo

Filter by:
NCT ID: NCT00214513 Completed - Clinical trials for Chronic Heart Failure

A Randomized Trial of Effect of Low-Cost Maintenance Training on Exercise Capacity, Quality of Life and Morbidity

Start date: June 2004
Phase: Phase 3
Study type: Interventional

The aim of the study is to determine whether a low-cost home-based training programme can maintain the achieved effect of physical training on exercise capacity and QOL in patients with Chronic Heart Failure.

NCT ID: NCT00212615 Completed - Clinical trials for C04.588.274.476.411.307

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

Start date: February 2004
Phase: Phase 2/Phase 3
Study type: Interventional

XELOX (Capecitabine and Oxaliplatin) is an effective and convenient regimen for patients with metastatic colorectal cancer. Chronomodulated therapy may reduce toxicity. Patients will be randomized to standard XELOX (Capecitabine 1000 mg/m² in the morning and 1000 mg/m² in the evening days 1-14 and short term Oxaliplatin 130 mg/m² day 1 in 30 minutes) or chronomodulated XELOX (Capecitabine 400 mg/m² in the morning and 1600 mg/m² in the evening days 1-14 and short term Oxaliplatin 130 mg/m² day 1 in 30 minutes). Bloodsamples will be collected and frozen and later examined for potential predictive factors

NCT ID: NCT00212589 Completed - Colorectal Cancer Clinical Trials

Patients Preference for Oral or i.v. Therapy

Start date: December 2002
Phase: Phase 3
Study type: Interventional

Until recently, bolus 5-flourouracil (FU) + folinic acid (FA) has been considered the standard chemotherapy for patients with colorectal cancer. Several studies have shown that Capecitabine is as effective as Mayo regimen. The Nordic FU/FA schedule was developed to be an active and tolerable bolus regimen. The Nordic regimen consists of a short (3 minutes) bolus injection of FU and 30 minutes later FA for 2 consecutive days each 2 weeks. In randomized studies efficacy is comparable to other FU/FA regimens. It is claimed that patients prefer oral therapy and in a randomized study comparing oral therapy (UFT/FA) and bolus FU/FA (Mayo) 84% preferred oral therapy. In the present randomized cross-over study patients were randomized for 3 courses of Nordic FU/FA followed by 2 courses of Capecitabine (or vice versa), and patients were asked for their preference.

NCT ID: NCT00209859 Completed - Clinical trials for Rheumatoid Arthritis

Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis

Start date: October 1998
Phase: Phase 4
Study type: Interventional

To investigate whether cyclosporine, added to methotrexate and steroid, increases the possibility of inflammatory management early in the disease; furthermore to investigate the possible steroid-sparing effect of cyclosporine in patients with recently diagnosed rheumatoid arthritis.

NCT ID: NCT00209495 Completed - Pain, Postoperative Clinical Trials

Effect of Paracetamol,Pregabalin and Dexamethasone on Pain and Opioid Requirements in Postoperative Patients

Start date: June 2005
Phase: Phase 4
Study type: Interventional

Women scheduled for abdominal hysterectomy needs postoperative pain treatment, i.e. morphine. Unfortunately morphine has side-effect: nausea, vomiting, sedation and dizziness, which is unpleasant for the patients and sometimes keeps them at bed longer time than needed. We investigate in new combinations of analgesics for postoperative pain, hoping to minimize the need for morphine.

NCT ID: NCT00209300 Completed - Ulcerative Colitis Clinical Trials

Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission

Start date: May 2005
Phase: Phase 3
Study type: Interventional

This is a multi-centre, randomised, controlled, investigator blinded study. The randomisation will be done centrally. The patients will be treated for 1 year, with clinical and laboratory assessments at 0, 4, 8 and 12 months. Endoscopic examination is at enrollment and on completion of the study (at relapse or after 12 months). Number of Subjects (Planned and Analysed): - 360 patients for demonstration of non-inferiority between once daily and twice daily; - 326 to be analysed in per-protocol (PP) analyses; and - 360 in intention-to-treat (ITT) analyses.

NCT ID: NCT00207688 Completed - Ulcerative Colitis Clinical Trials

A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

Start date: August 31, 2004
Phase:
Study type: Observational

The purpose of this study is to evaluate long-term safety information of infliximab in patients who have participated in infliximab clinical studies in ulcerative colitis.

NCT ID: NCT00207064 Completed - Schizophrenia Clinical Trials

Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia

Start date: April 2004
Phase: N/A
Study type: Interventional

We want to relate disturbances in first-episode schizophrenic patients in serotonin 5-HT2A receptors, brain structure, brain function, and information processing to each other and to psychopathology. Additionally, we want to examine the influence of 5-HT2A receptor blockade on these disturbances. We expect disturbances in the serotonergic system at baseline to correlate with specific structural and functional changes and with disruption in information processing as measured with psychophysiological and neurocognitive methods - and we expect 5-HT2A receptor blockade to reverse some of the functional and cognitive impairments. We do not expect any effect of treatment on brain structure

NCT ID: NCT00207038 Completed - Asthma Clinical Trials

Airway Inflammation in Swimmers

Start date: September 2005
Phase: N/A
Study type: Observational

Studies have shown that the prevalence of respiratory symptoms, airway hyperresponsiveness (AHR) and asthma is high and increasing in elite athletes. The inflammation seen in the airways of elite athletes might differ from the inflammation seen in the airways of "ordinary" asthmatics and it might represent a different kind of asthma. The primary purposes are 1. To investigate the type of airway inflammation in young swimmers. 2. To investigate the acute changes in airway inflammation after a short training session.

NCT ID: NCT00206999 Completed - Healthy Volunteers Clinical Trials

The Effect of Imipramine on Early Information Processing

Start date: September 2004
Phase: N/A
Study type: Interventional

We wanted to compare the relation of two different psychophysiological paradigms (PrePulse Inhibition of the startle response = PPI and P50 suppression) to each other. Additionally, we wanted to test the effect of the combined serotonin- and noradrenaline re-uptake inhibitor, imipramine, on these measures. The primary hypothesis was that PPI and P50 gating would not correlate with each other at baseline. The secondary hypothesis was that increased noradrenergic and serotonergic activity would disrupt PPI as well as P50 gating.